Panbela Therapeutics Inc. buy Maxim Group
Start price
20.03.23
/
50%
€6.36
Target price
20.03.24
-
Performance (%)
-96.67%
End price
21.03.24
-
Summary
This prediction is currently being closed. The BUY prediction by Maxim_Group for Panbela Therapeutics Inc. is performing very badly with a performance of -96.67%. Maxim_Group has 50% into this predictionPerformance without dividends (%)
| Name | 1w | 1m | 1y | 3y |
|---|---|---|---|---|
| Panbela Therapeutics Inc. | - | - | - | - |
| iShares Core DAX® | 0,79 % | 1,97 % | 13,39 % | 49,83 % |
| iShares Nasdaq 100 | 4,23 % | 4,34 % | 39,72 % | 89,76 % |
| iShares Nikkei 225® | 3,29 % | 6,99 % | 49,89 % | 64,38 % |
| iShares S&P 500 | 2,50 % | 2,76 % | 30,23 % | 64,25 % |
Comments by Maxim_Group for this prediction
In the thread Panbela Therapeutics Inc. diskutieren
Panbela Therapeutics, Inc. (NASDAQ: PBLA) was upgraded by analysts at Maxim Group from a "hold" rating to a "buy" rating.
Ratings data for PBLA provided by MarketBeat
In the thread Trading Panbela Therapeutics Inc.
Die von Maxim_Group gewählte maximale Laufzeit wurde überschritten

